Abstract
Migraine is a common, recurrent, severe headache that interferes with normal functioning and quality of life (QOL). This prospective observational study was conducted to evaluate and compare the effectiveness and safety flunarizine(10mg), calcium channel antagonist, and propranolol(40mg) in the prophylaxis of migraine with or without aura. This Study included 70 patients of migraine and was divided into 2 treatment groups. SF 36 v1 questionaire were used for the evaluation of health related QOL. Both treatment groups led to a significant reduction in severity, frequency and duration after one month. The difference between two treatments was statistically significant. Sedation was noted with both treatments. Propranolol can be the better treatment for reducing the severity and frequency of migraine.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
